×
S&P 500   3,866.82 (+0.92%)
DOW   31,193.20 (+0.73%)
QQQ   290.13 (+1.10%)
AAPL   143.59 (+1.43%)
MSFT   267.26 (+1.68%)
META   171.01 (+1.68%)
GOOGL   2,301.58 (+1.60%)
AMZN   115.07 (+1.38%)
TSLA   697.24 (-0.28%)
NVDA   152.52 (+1.92%)
NIO   20.72 (-6.58%)
BABA   119.44 (-0.57%)
AMD   75.82 (+0.82%)
MU   57.90 (+2.06%)
CGC   2.68 (-1.11%)
T   21.14 (-0.14%)
GE   61.82 (-0.34%)
F   11.15 (-0.45%)
DIS   96.52 (-0.68%)
AMC   12.46 (-2.50%)
PFE   52.69 (+2.03%)
PYPL   73.74 (-0.89%)
NFLX   185.34 (-0.29%)
S&P 500   3,866.82 (+0.92%)
DOW   31,193.20 (+0.73%)
QQQ   290.13 (+1.10%)
AAPL   143.59 (+1.43%)
MSFT   267.26 (+1.68%)
META   171.01 (+1.68%)
GOOGL   2,301.58 (+1.60%)
AMZN   115.07 (+1.38%)
TSLA   697.24 (-0.28%)
NVDA   152.52 (+1.92%)
NIO   20.72 (-6.58%)
BABA   119.44 (-0.57%)
AMD   75.82 (+0.82%)
MU   57.90 (+2.06%)
CGC   2.68 (-1.11%)
T   21.14 (-0.14%)
GE   61.82 (-0.34%)
F   11.15 (-0.45%)
DIS   96.52 (-0.68%)
AMC   12.46 (-2.50%)
PFE   52.69 (+2.03%)
PYPL   73.74 (-0.89%)
NFLX   185.34 (-0.29%)
S&P 500   3,866.82 (+0.92%)
DOW   31,193.20 (+0.73%)
QQQ   290.13 (+1.10%)
AAPL   143.59 (+1.43%)
MSFT   267.26 (+1.68%)
META   171.01 (+1.68%)
GOOGL   2,301.58 (+1.60%)
AMZN   115.07 (+1.38%)
TSLA   697.24 (-0.28%)
NVDA   152.52 (+1.92%)
NIO   20.72 (-6.58%)
BABA   119.44 (-0.57%)
AMD   75.82 (+0.82%)
MU   57.90 (+2.06%)
CGC   2.68 (-1.11%)
T   21.14 (-0.14%)
GE   61.82 (-0.34%)
F   11.15 (-0.45%)
DIS   96.52 (-0.68%)
AMC   12.46 (-2.50%)
PFE   52.69 (+2.03%)
PYPL   73.74 (-0.89%)
NFLX   185.34 (-0.29%)
S&P 500   3,866.82 (+0.92%)
DOW   31,193.20 (+0.73%)
QQQ   290.13 (+1.10%)
AAPL   143.59 (+1.43%)
MSFT   267.26 (+1.68%)
META   171.01 (+1.68%)
GOOGL   2,301.58 (+1.60%)
AMZN   115.07 (+1.38%)
TSLA   697.24 (-0.28%)
NVDA   152.52 (+1.92%)
NIO   20.72 (-6.58%)
BABA   119.44 (-0.57%)
AMD   75.82 (+0.82%)
MU   57.90 (+2.06%)
CGC   2.68 (-1.11%)
T   21.14 (-0.14%)
GE   61.82 (-0.34%)
F   11.15 (-0.45%)
DIS   96.52 (-0.68%)
AMC   12.46 (-2.50%)
PFE   52.69 (+2.03%)
PYPL   73.74 (-0.89%)
NFLX   185.34 (-0.29%)
TSE:ACB

Aurora Cannabis Stock Forecast, Price & News

C$1.81
+0.03 (+1.69%)
(As of 07/6/2022 03:21 PM ET)
Add
Compare
Today's Range
C$1.74
C$1.84
50-Day Range
C$1.58
C$4.09
52-Week Range
C$1.56
C$11.09
Volume
1.21 million shs
Average Volume
2.11 million shs
Market Capitalization
C$538.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$3.68

Aurora Cannabis MarketRank™ Forecast

Analyst Rating
Hold
1.75 Rating Score
Upside/​Downside
110.2% Upside
C$3.68 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.17mentions of Aurora Cannabis in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.19 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive ACB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter.

Aurora Cannabis logo

About Aurora Cannabis (TSE:ACB) Stock

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

ACB Stock News Headlines

Aurora Cannabis Inc - Stock Trailing Returns ACB
Is Aurora Cannabis Too Cheap to Pass Up Right Now?
Aurora Cannabis Announces More Layoffs, Here's Why
It's a Cannabis Buyers' Market
Why Aurora Cannabis Crumbled Today
Aurora Cannabis Earnings, Revenue miss in Q3
See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
1,761
Year Founded
N/A

Company Calendar

Last Earnings
5/15/2017
Today
7/06/2022
Next Earnings (Estimated)
9/26/2022

Price Target and Rating

Average Stock Price Forecast
C$3.68
High Stock Price Forecast
C$7.50
Low Stock Price Forecast
C$1.85
Forecasted Upside/Downside
+103.2%
Consensus Rating
Hold
Rating Score (0-4)
1.75
Research Coverage
8 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$225.95 million
Cash Flow
C$2.05 per share
Book Value
C$4.86 per share

Miscellaneous

Free Float
N/A
Market Cap
C$538.92 million
Optionable
Not Optionable
Beta
N/A














Aurora Cannabis Frequently Asked Questions

Should I buy or sell Aurora Cannabis stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last twelve months. There are currently 2 sell ratings and 6 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Aurora Cannabis stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACB, but not buy additional shares or sell existing shares.
View analyst ratings for Aurora Cannabis
or view top-rated stocks.

What is Aurora Cannabis' stock price forecast for 2022?

8 brokers have issued 12-month target prices for Aurora Cannabis' stock. Their ACB stock forecasts range from C$1.85 to C$7.50. On average, they anticipate Aurora Cannabis' share price to reach C$3.68 in the next year. This suggests a possible upside of 106.6% from the stock's current price.
View analysts' price targets for Aurora Cannabis
or view top-rated stocks among Wall Street analysts.

How has Aurora Cannabis' stock price performed in 2022?

Aurora Cannabis' stock was trading at C$6.85 at the start of the year. Since then, ACB stock has decreased by 74.0% and is now trading at C$1.78.
View the best growth stocks for 2022 here
.

When is Aurora Cannabis' next earnings date?

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Monday, September 26th 2022.
View our earnings forecast for Aurora Cannabis
.

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc. (TSE:ACB) posted its quarterly earnings data on Monday, May, 15th. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). The company earned $5.18 million during the quarter, compared to analysts' expectations of $7.44 million.
View Aurora Cannabis' earnings history
.

Who are Aurora Cannabis' key executives?

Aurora Cannabis' management team includes the following people:
  • Mr. Miguel Martin, CEO & Director (Age 50, Pay $2.15M)
  • Mr. Glen Ibbott, Chief Financial Officer
  • Mr. Carey Squires, Exec. VP of Corp. Devel. & Strategy
  • Mr. Andre Jerome, Exec. VP of Global Bus. Devel.
  • Mr. Alex Miller, Exec. VP of Operations & Supply Chain
  • Dave Aird, Exec. VP of Information Services
  • Ananth Krishnan, VP of Capital Markets & Investor Relations
  • Nathalie Clark, Exec. VP, Gen. Counsel & Corp. Sec.
  • Michelle Lefler, VP of Communications & PR
  • Ms. Lori Schick, Exec. VP of HR

What other stocks do shareholders of Aurora Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include (CGC), Canopy Growth (WEED), Aphria (APHA), OrganiGram (OGI), Aurora Cannabis (ACBFF), Cronos Group (CRON), Micron Technology (MU), Alibaba Group (BABA), Green Organic Dutchman (TGOD) and Advanced Micro Devices (AMD).

What is Aurora Cannabis' stock symbol?

Aurora Cannabis trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ACB."

How do I buy shares of Aurora Cannabis?

Shares of ACB and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Aurora Cannabis' stock price today?

One share of ACB stock can currently be purchased for approximately C$1.78.

How much money does Aurora Cannabis make?

Aurora Cannabis (TSE:ACB) has a market capitalization of C$529.99 million and generates C$225.95 million in revenue each year.

How many employees does Aurora Cannabis have?

Aurora Cannabis employs 1,761 workers across the globe.

How can I contact Aurora Cannabis?

Aurora Cannabis' mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The official website for Aurora Cannabis is auroramj.com. The company can be reached via phone at +1-604-3625207.

This page (TSE:ACB) was last updated on 7/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.